Late-onset isavuconazole-induced liver injury
Antifungal agents account for approximately 3% of Drug-Induced Liver Injury (DILI) cases. Isavuconazole is a novel triazole, and experience with long-term use of it is lacking. We report a case of late-onset DILI occurring after 11 months of isavuconazole therapy in a 55-year old man of Angolan desc...
Main Authors: | Felix Bongomin, Isabel Rodriguez-Goncer, Carol Lorden, Akaninyene Otu, Rohit Bazaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Medical Mycology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753918300836 |
Similar Items
-
Utility of St. George’s respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis
by: Felix Bongomin, et al.
Published: (2021-07-01) -
Isavuconazole as salvage therapy for mucormycosis
by: Bianca Graves, et al.
Published: (2016-03-01) -
Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01) -
Isavuconazole Kinetic Exploration for Clinical Practice
by: Léa Darnaud, et al.
Published: (2018-10-01) -
Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
by: Marta Ilharco, et al.
Published: (2019-01-01)